Delivery Order SPE2DB20D7059-SPE2DB24FQMW7

Award Date 9/16/24
Potential Completion Date 9/17/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.13 firm fixed price delivery order is for the supply of 4568513111 - CLINDAMYCIN 150MG 100S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4,554,462,418 units of Clindamycin HCL 300 mg capsules in 100 count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 18, 2021. The contract has a ceiling value of $1,239.28 and is a firm fixed-price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
The Defense Logistics Agency awarded a $149,610 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clindamycin hydrochloride 150 mg capsules. Under this order, Amerisourcebergen will deliver 500 units of the generic antibiotic to a facility in Conshohocken, Pennsylvania by June 26, 2023 in support of the Department of Defense's medical supply needs. As a major pharmaceutical distributor, Amerisourcebergen routinely fulfills orders under the DLA's Pharmaceutical Prime...
This federal contract award is a delivery order valued at $15,053.24 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The award is for the provision of 4,558,161,196 units of the medication Clindamycin HCL 300 mg capsules. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
This federal contract award, valued at $1,154.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $14,227.04 firm-fixed-price contract is for the supply of 4,558,931,304 units of Clindamycin 60GM 1S, a pharmaceutical product. This order is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which provides a wide range of medical commodities to...
The Defense Logistics Agency awarded a $11,730 delivery order to Amerisourcebergen Drug Corporation for 150 mg capsules of clindamycin hydrochloride. As the prime contractor, Amerisourcebergen will supply 100 count bottles of the antibiotic medication to fulfill requirements under the contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order is for a one day period from July 26, 2023 through July 27, 2023 to support the...
The Defense Logistics Agency awarded a $215,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150mg clindamycin hydrochloride capsules. Under this contract, Amerisourcebergen will deliver 100 count bottles of the generic antibiotic to a facility in Conshohocken, Pennsylvania by September 15, 2023 to support the Department of Defense's medical supply needs. As a major pharmaceutical distributor, Amerisourcebergen routinely fulfills orders under the DLA's Pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,557,346,855 units of Clindamycin HCL 300 mg capsules in 100-count bottles. The contract has a ceiling value of $1,063.78 and was awarded on May 25, 2022, with a completion date of May 26, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQMW7
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,148.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,814,685 units of Clindamycin HCL 150 mg capsules. This contract has an ultimate completion date of September 17, 2024 and does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies to provide a wide range of critical medical commodities, including specialty medications, generic drugs, vaccines, and medical supplies to support military treatment facilities, veterans' healthcare programs, and other government healthcare needs nationwide.

Generated 12/16/24, 2:34 PM